Implementation of screening test checkpoints in Botswana (Representational Image: Unsplash) 
Medicine

Botswana Implements Mpox Screening at Entry Points to Curb Spread

New Health Measures Aim to Detect and Contain Mpox by Screening Checkpoints in Botswana.

MBT Desk

Gaborone, Botswana — Health officials in Botswana have started screening travelers for mpox at the country's entry points.

Neighboring South Africa has recorded three deaths as a result of the dangerous strain of mpox, and Botswana is anxious to keep out the rapidly spreading disease.

Although we have not recorded any case of mpox in Botswana, I want to take this opportunity to assure Botswana that we have significantly enhanced our broader surveillance systems.We are currently intensifying our surveillance at key entry points, which is borders and airports, focusing on high-risk areas.
Dr Edwin Dikoloti, MInister of Health, Botswana

South Africa shares a 1,900-kilometer border with Botswana and as of Aug. 5 had recorded three mpox deaths. In Africa, the disease has claimed the lives of more than 500 people since the beginning of the year.

Botswana Public Health Institute Acting Director Dr.Thebeyame Matsheka says travelers will be required to fill out self-assessment forms at border checkpoints.

There are sometimes where, through just random checks, we might identify someone who appears not to be well, they will take those travelers aside and investigate further.
Dr. Thebeyame Matsheka, Botswana Public Health Institute Acting Director
Implementation of screening test in all international check points. (Representational Image: Unsplash)

Meanwhile, Dikoloti said Botswana is engaging with international partners for the supply of vaccines.

According to Africa's Centers for Disease Control and Prevention, the continent has about 200,000 vaccine doses against a requirement of at least 10 million doses.

Medication to be used for the management of mpox is available at health facilities throughout the country.

"Vaccines exist for mpox but they are not widely available," Dikoloti added.

The World Health Organization country representative, Juliet Bataringaya, says the scale of the mpox vaccination will not be broad because the disease affects countries differently.

“We need to have a good understanding of the epidemiology in each and every country, because it is different and to understand the transmission patterns," Bataringaya said. "These will then guide on the use of vaccines in a more targeted way to have maximum public health impact."

She said there won't be the kind of mass vaccination effort implemented during the COVID pandemic because the modes of transmission are different.

(VOA/PBVSVP)

Rise in Myopia Among Children Post-COVID: Growing Concern and Preventive Measures

From Dentistry to Words: Dr. Rashmi Maniya on Medical Writing and Oral Health Advocacy

Bombay HC Grants Anticipatory Bail to Doctor Duo Accused of Cheating 5 People of ₹41L

Karnataka Hikes Hospital Fees: BMCRI Leads the Way

Metropolis Healthcare Reveals Groundbreaking Genomic Insights for Lung Cancer Awareness Month